Buy SGT-263/151/25/67/78 for sale online from USA vendor
Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
What is SGT-263/151/25/67/78?
In recent years, synthetic cannabinoids have garnered prominence for their adverse effects on the human body. These synthetic medications are intended to replicate the effects of marijuana's natural cannabinoids, but their chemical structure is altogether different. Three synthetic cannabinoids have been offered as designer drugs: 5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263), CUMYL-PEGACLONE (SGT-151), and 5F-CUMYL-PINACA (also known as SGT-25 and occasionally sold in e-cigarette form as C-Liquid). The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) discovered them for the first time in 2015, and their potential risks have been the subject of extensive research.
The Science behind Synthetic Cannabinoids
5F-CUMYL-P7AICA: 5F-CUMYL-P7AICA is a synthetic cannabinoid based on pyrrolo[2,3-b]pyridine-3-carboxamide that mimics the effects of marijuana. It attaches to the same brain receptors as natural cannabinoids, causing comparable effects. Nonetheless, the chemical makeup is distinct and might have far stronger and more damaging effects on the human body.
CUMYL-PEGACLONE: CUMYL-PEGACLONE is a gamma-carboline-based synthetic cannabinoid whose structure is comparable to that of other gamma-carboline cannabinoids reported by Bristol-Myers Squibb in 2001. The gamma-carboline core structure had never been observed in a synthetic cannabinoid, making it impossible to anticipate its effects on the human body.
5F-CUMYL-PINACA: 5F-CUMYL-PINACA is a potent agonist for cannabinoid receptors. It is an indazole-3-carboxamide-based synthetic cannabinoid. It binds to the CB1 and CB2 receptors in the brain and produces effects comparable to those of natural cannabinoids. However, 5F-CUMYL-PINACA is far more potent, with original patents claiming a selectivity of about 4x for CB1 and EC50 values of 0.1 nM for human CB1 receptors and 0.37 nM for human CB2 receptors. Recent experiments have discovered varied EC50 values for CB1 and CB2; however, these values cannot be directly compared due to the various assay methodologies employed.
The Dangers of Synthetic Cannabinoids
The use of synthetic cannabinoids can result in severe health issues, such as convulsions, hallucinations, an elevated heart rate, vomiting, and in rare circumstances, death. Due to the intensity of the chemicals employed in the medications and the fact that they bind to brain receptors considerably more strongly than natural cannabinoids, these severe side effects are produced.
What are the long-term consequences of synthetic cannabis use?
Since synthetic cannabinoids are relatively new and have not been fully explored, their long-term consequences are unknown. However, many studies indicate that they can harm the brain and other organs, resulting in long-term health issues. In addition, the unpredictable nature of the compounds utilized in these medications makes it impossible to determine the long-term consequences.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics